Mometasone Furoate (Elocom, Asmanex Twisthaler) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 17, 2026
Also sold as: Elocom, Asmanex Twisthaler, Nasonex, Mosaspray
Some Mometasone Furoate products are in shortage in Canada (3 of 15 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
A corticosteroid used to treat nasal allergies, asthma and inflammatory skin conditions.
Products affected
3 / 15
In shortage since
Feb 12, 2025
Est. full return
Aug 7, 2026
Reports on file
110
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ASMANEX TWISTHALER
100MCG · POWDER · ORGANON CANADA INC.
DIN 02438690 · since May 26, 2026, est. end Aug 7, 2026 · Delay in shipping of the drug.
Active shortage
APO-MOMETASONE
50MCG · SPRAY, METERED DOSE · APOTEX INC
DIN 02403587 · since Apr 21, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-MOMETASONE
50MCG · SPRAY, METERED DOSE · TEVA CANADA LIMITED
DIN 02475863 · since Feb 12, 2025, no end estimate · Disruption of the manufacture of the drug.
Anticipated
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596 · Delay in shipping of the drug.
Anticipated
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596 · Delay in shipping of the drug.
To be discontinued
ELOCOM
0.1% · LOTION · ORGANON CANADA INC.
DIN 00871095
Resolved
TARO-MOMETASONE CREAM
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02367157 · ended May 21, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-MOMETASONE LOTION
0.1% · LOTION · TARO PHARMACEUTICALS INC
DIN 02266385 · ended Mar 26, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-MOMETASONE LOTION
0.1% · LOTION · TARO PHARMACEUTICALS INC
DIN 02266385 · ended Mar 26, 2026 · Disruption of the manufacture of the drug.
Resolved
ASMANEX TWISTHALER
100MCG · POWDER · ORGANON CANADA INC.
DIN 02438690 · ended Aug 27, 2025 · Delay in shipping of the drug.
Resolved
ASMANEX TWISTHALER
400MCG · POWDER · ORGANON CANADA INC.
DIN 02243596 · ended Aug 15, 2025 · Delay in shipping of the drug.
Resolved
TEVA-MOMETASONE
0.1% · OINTMENT · TEVA CANADA LIMITED
DIN 02248130 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Mometasone Furoate is currently affected by 3 active shortage reports filed with Health Canada by ORGANON CANADA INC., APOTEX INC, TEVA CANADA LIMITED.
The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Mometasone Furoate is classified under “OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS” (ATC R03BA).
Recent changes
Jul 17, 2026
New report filed
Jul 17, 2026
New report filed
Common questions
What is Mometasone Furoate used for?
A corticosteroid used to treat nasal allergies, asthma and inflammatory skin conditions.
When will Mometasone Furoate be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Mometasone Furoate in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.